261 related articles for article (PubMed ID: 29091189)
21. Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms.
Bazaz R; Chapman AL; Winstanley TG
J Antimicrob Chemother; 2010 Jul; 65(7):1510-3. PubMed ID: 20460397
[TBL] [Abstract][Full Text] [Related]
22. An outcomes analysis of outpatient parenteral antibiotic therapy (OPAT) in a large Asian cohort.
Seetoh T; Lye DC; Cook AR; Archuleta S; Chan M; Sulaiman Z; Zhong L; Llorin RM; Balm M; Fisher D
Int J Antimicrob Agents; 2013 Jun; 41(6):569-73. PubMed ID: 23453619
[TBL] [Abstract][Full Text] [Related]
23. Outpatient parenteral antimicrobial therapy for infective endocarditis: a cost-effective strategy.
Lacroix A; Revest M; Patrat-Delon S; Lemaître F; Donal E; Lorléac'h A; Arvieux C; Michelet C; Tattevin P
Med Mal Infect; 2014 Jul; 44(7):327-30. PubMed ID: 25022891
[TBL] [Abstract][Full Text] [Related]
24. [Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections].
Galpérine T; Ader F; Piriou P; Judet T; Perronne C; Bernard L
Med Mal Infect; 2006 Mar; 36(3):132-7. PubMed ID: 16580802
[TBL] [Abstract][Full Text] [Related]
25. Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme.
Huck D; Ginsberg JP; Gordon SM; Nowacki AS; Rehm SJ; Shrestha NK
J Antimicrob Chemother; 2014 Jan; 69(1):228-33. PubMed ID: 23887864
[TBL] [Abstract][Full Text] [Related]
26. The use, appropriateness and outcomes of outpatient parenteral antimicrobial therapy.
Hodgson KA; Huynh J; Ibrahim LF; Sacks B; Golshevsky D; Layley M; Spagnolo M; Raymundo CM; Bryant PA
Arch Dis Child; 2016 Oct; 101(10):886-93. PubMed ID: 27166221
[TBL] [Abstract][Full Text] [Related]
27. Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates.
Mansour O; Heslin J; Townsend JL
J Antimicrob Chemother; 2018 Nov; 73(11):3181-3188. PubMed ID: 30085088
[TBL] [Abstract][Full Text] [Related]
28. A retrospective analysis of adverse events among patients receiving daptomycin versus vancomycin during outpatient parenteral antimicrobial therapy.
Schrank GM; Wright SB; Branch-Elliman W; LaSalvia MT
Infect Control Hosp Epidemiol; 2018 Aug; 39(8):947-954. PubMed ID: 29893658
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program.
Quintens C; Steffens E; Jacobs K; Schuermans A; Van Eldere J; Lagrou K; De Munter P; Derdelinckx I; Peetermans WE; Spriet I
Infection; 2020 Jun; 48(3):357-366. PubMed ID: 32060859
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of outpatient parenteral antibiotic therapy for infective endocarditis: a ten-year prospective study.
Cervera C; del Río A; García L; Sala M; Almela M; Moreno A; Falces C; Mestres CA; Marco F; Robau M; Gatell JM; Miró JM;
Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):587-92. PubMed ID: 21723004
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of daptomycin in outpatient parenteral antimicrobial therapy: a prospective and multicenter cohort study (DAPTODOM trial).
Cervera C; Sanroma P; González-Ramallo V; García de la María C; Sanclemente G; Sopena N; Pajarón M; Segado A; Mirón M; Antón F; Basterretxea A; Cuende A; Miró JM;
Infect Dis (Lond); 2017 Mar; 49(3):200-207. PubMed ID: 27820968
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of an emergency department to outpatient parenteral antibiotic therapy program for cellulitis.
Yadav K; Suh KN; Eagles D; Thiruganasambandamoorthy V; Wells GA; Stiell IG
Am J Emerg Med; 2019 Nov; 37(11):2008-2014. PubMed ID: 30824277
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections.
Seaton RA; Sharp E; Bezlyak V; Weir CJ
Int J Antimicrob Agents; 2011 Sep; 38(3):243-8. PubMed ID: 21741221
[TBL] [Abstract][Full Text] [Related]
34. Tigecycline use in the outpatient parenteral antibiotic therapy setting.
Ingram PR; Rawlins MD; Murray RJ; Roberts JA; Manning L
Eur J Clin Microbiol Infect Dis; 2016 Oct; 35(10):1673-7. PubMed ID: 27325439
[TBL] [Abstract][Full Text] [Related]
35. Safety and clinical outcomes of outpatient parenteral antibiotic therapy for infective endocarditis in Christchurch, New Zealand: A retrospective cohort study.
Campbell PO; Gallagher K; Dalton SC; Metcalf SCL; Douglas NM; Chambers ST
Int J Infect Dis; 2023 Sep; 134():172-176. PubMed ID: 37331565
[TBL] [Abstract][Full Text] [Related]
36. Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare setting.
Kieran J; O'Reilly A; Parker J; Clarke S; Bergin C
Eur J Clin Microbiol Infect Dis; 2009 Nov; 28(11):1369-74. PubMed ID: 19697069
[TBL] [Abstract][Full Text] [Related]
37. OPAT: proof of concept in a peripheral Belgian hospital after review of the literature.
Smismans A; Vantrappen A; Verbiest F; Indevuyst C; Van den Poel B; von Winckelmann S; Peeters A; Ombelet S; Lybeert P; Heremans A; Frans E; Ho E; Frans J
Acta Clin Belg; 2018 Aug; 73(4):257-267. PubMed ID: 29385901
[TBL] [Abstract][Full Text] [Related]
38. Comparative outcomes of β-lactam antibiotics in outpatient parenteral antibiotic therapy: treatment success, readmissions and antibiotic switches.
Lee B; Tam I; Weigel B; Breeze JL; Paulus JK; Nelson J; Allison GM
J Antimicrob Chemother; 2015 Aug; 70(8):2389-96. PubMed ID: 26024869
[TBL] [Abstract][Full Text] [Related]
39. Costs of outpatient parenteral antimicrobial therapy (OPAT) administered by Hospital at Home units in Spain.
González-Ramallo VJ; Mirón-Rubio M; Mujal A; Estrada O; Forné C; Aragón B; Rivera AJ
Int J Antimicrob Agents; 2017 Jul; 50(1):114-118. PubMed ID: 28499957
[TBL] [Abstract][Full Text] [Related]
40. Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study.
Shrestha NK; Mason P; Gordon SM; Neuner E; Nutter B; O'Rourke C; Rehm SJ
J Antimicrob Chemother; 2014 May; 69(5):1407-15. PubMed ID: 24398341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
